Search Results

Adavosertib 100 mg  | 99.58%

TargetMol

MK-1775 is a small molecule inhibitor of the checkpoint kinase WEE1 (IC50: 5.2 nM). It hinders the G2 DNA damage checkpoint.

More Information Supplier Page

Axitinib 100 mg  | 99.27%

TargetMol

Axitinib is an orally bioavailable tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.7, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ, respectively.

More Information Supplier Page

Fluticasone (propionate) 50 mg  | 99.65%

TargetMol

Fluticasone propionate (CCI-187881), derived from fluticasone used to remedy asthma and allergic rhinitis, is a high affinity, selective GR (glucocorticoid receptor) agonist.

More Information Supplier Page

Felypressin 10 mg  | Purity Not Available

TargetMol

Felypressin is a synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.

More Information Supplier Page

Felypressin 2 mg  | Purity Not Available

TargetMol

Felypressin is a synthetic analog of LYPRESSIN with a PHENYLALANINE substitution at residue 2. Felypressin is a vasoconstrictor with reduced antidiuretic activity.

More Information Supplier Page

Axitinib 200 mg  | 99.27%

TargetMol

Axitinib is an orally bioavailable tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.7, 1.6 nM for VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ, respectively.

More Information Supplier Page

Fluticasone (propionate) 5 mg  | 99.65%

TargetMol

Fluticasone propionate (CCI-187881), derived from fluticasone used to remedy asthma and allergic rhinitis, is a high affinity, selective GR (glucocorticoid receptor) agonist.

More Information Supplier Page